Evolent Health, Inc.
EVH
$4.20
$0.000.00%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.82% | -1,346.68% | -273.95% | 31.75% | 8.64% |
| Total Depreciation and Amortization | -23.02% | -24.29% | -23.47% | 195.13% | -9.31% |
| Total Amortization of Deferred Charges | 31.52% | -6.46% | 3.62% | -19.62% | -14.70% |
| Total Other Non-Cash Items | 12.05% | 67.02% | 127.29% | -25.88% | -34.08% |
| Change in Net Operating Assets | -64.10% | -128.54% | 39.90% | -175.93% | -128.31% |
| Cash from Operations | -15.31% | -241.64% | -7.01% | -129.35% | -69.15% |
| Capital Expenditure | 48.18% | -416.96% | -94.49% | 142.48% | -154.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.11% | 88.68% | -- | -- | -3,536.62% |
| Cash from Investing | 55.59% | -347.02% | -34.54% | -229.31% | -221.06% |
| Total Debt Issued | -- | -- | -- | -85.04% | -- |
| Total Debt Repaid | -- | -- | -11,714.74% | 100.13% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -48.27% |
| Repurchase of Common Stock | -5,758.82% | 92.31% | 67.96% | 67.16% | 56.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 62.43% | 8.80% | 9.87% | 6.90% | -0.75% |
| Other Financing Activities | 75.96% | 95.64% | -222.84% | 176.28% | 78.07% |
| Cash from Financing | -364.20% | 91.36% | 624.73% | 214.93% | 75.89% |
| Foreign Exchange rate Adjustments | -548.39% | -245.83% | 160.53% | -655.56% | 71.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -246.27% | -4.55% | 891.41% | 4,965.03% | -159.76% |